Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study

ConclusionPas-LAR is effective and safe and the early identification of responders is possible just after the first administration.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research